Skip to content

Public FDA record

Z-1426-2010: REF 822 IMUBIND(R) Plasma PAI-1 ELISA The intended use: Product is an enzyme-linked immunosorbent assay

Recall record Z-1426-2010 for American Diagnostica, Inc.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1426-2010
Company in FDA record
American Diagnostica, Inc.
FDA classification date
Apr 21, 2010
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 20, 2026
Recall classification
Unknown — no matched enforcement classification

Reason stated in the source

Unacceptable microwell to microwell variation in the section of the plate that is typically used for the calibrators

Source facts

Action
Three emails "REF 822 lot 102401 needs to be recalled" dated March 1, 2010 was sent to three customers. The emails described the product, problem and action to be taken by the customers. The customers should send the kit to the firm (SEKISUI american diagnostica inc.) attention of Leigh Ayres, Director, Regulatoy Affairs and Quality Assurance. If you have any question, please call 1-203-602-7777.
Initiated
2010-03-05
Root cause
Process control
Terminated
2016-07-29
Distribution
Worldwide distribution: USA and UK, Taiwan and Korea.
Recall number
Z-1426-2010
Recall status
Terminated
CDRH record ID
89355
FDA classified
2010-04-21
Recall event number
54858

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗